Companies Dominating the Leukapheresis Landscape
- BioLineRx Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Gilead Sciences, Inc.
- Haemonetics Corporation
- Charles River Laboratories
- Fresenius SE & Co.
- StemExpress, LLC
- AllCells, LLC
- Cerus Corporation
- Hemacare Corporation
- Macopharma SA.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Leukapheresis Market in 2025 is evaluated at USD 226.13 million.
The global market size was valued at more than USD 208.76 million in 2024 and is expected to register a CAGR of over 10.4%, exceeding USD 755.52 million revenue by 2037.
North America is expected to accumulate USD 271.99 million by 2037, attributed to a rise in neurological illnesses and blood disorders like leukemia.
The major players in the market include BioLineRx Ltd., Gilead Sciences, Inc., Haemonetics Corporation, Charles River Laboratories, Fresenius SE & Co., StemExpress, LLC, AllCells, LLC, Cerus Corporation, Hemacare Corporation, Macopharma SA.
